[ad_1]
The Stem Cell Network and Capital BioVentures have formed a strategic partnership aimed at advancing the commercialization of regenerative medicine innovations in Canada. This collaboration seeks to provide emerging biotech companies in the regenerative medicine sector with critical resources — from business advisory services to funding and mentorship — in order to help them navigate the complexities of bringing transformative health solutions to market.
Key initiatives in the partnership include offering up to 60 hours of expert consulting to selected companies, supporting The Stem Cell Network’s new Incubation Award Program, and jointly contributing financial and advisory resources to foster the growth of promising Canadian regenerative medicine startups.
This effort aligns with The Stem Cell Network’s 2025–2029 Strategic Plan, which emphasizes commercialization readiness, industry engagement, and enhancing the entrepreneurial expertise of Canada’s regenerative medicine community.
Image Credit: The Stem Cell Network and Capital BioVentures
[ad_2]
Source link